Intravitreal Injections with Vascular Endothelial Growth Factor Inhibitors: A Practical Approach
Anne-Sofie Petri, Kirstine B. Boysen, Lasse Jørgensen Cehofski, Elon H. C. van Dijk, Chantal Dysli, Josefine Fuchs, Rodolfo Mastropasqua, Yousif Subhi
Abstract
Intravitreal injections with vascular endothelial growth factor inhibitors constitute the most prevalent ophthalmic procedure in developed countries. Historically, there has been steady growth in the number of treatments performed of this kind, and projection studies estimate further growth in such treatments in the future. We provide a practical approach to intravitreal injections and discuss important aspects relating to the setting, the patient, the procedure, and the information given to the patient.
Topics & Concepts
MedicineVascular endothelial growth factorOphthalmologyRanibizumabGrowth factorVEGF receptorsSurgeryBevacizumabInternal medicineChemotherapyReceptorRetinal Diseases and TreatmentsRetinal and Optic ConditionsRetinal and Macular Surgery